Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'
By Ryan Davis · December 23, 2025, 7:56 PM EST
Amarin Pharma Inc. on Tuesday urged the U.S. Supreme Court to reject the U.S. solicitor general's call to hear a patent case involving generic drug "skinny labels," saying the dispute over...
To view the full article, register now.